Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine.
The relationship between arsenic exposure and DNA damage in patients with acute or chronic arsenic poisoning was analyzed. Urinary 8-hydroxydeoxyguanine (8-OHdG) concentrations were measured as an indication of oxidative DNA damage. A remarkable increase in 8-OHdG in the urine was observed in 60% of 52 patients with acute arsenic poisoning from the accidental oral intake of the arsenic trioxide. This was two- to threefold higher than levels in normal healthy subjects (n = 248). There was a clear relationship between arsenic concentrations in urine after acute poisoning and elevated levels of 8-OHdG. Levels of urinary 8-OHdG returned to normal within 180 days after the acute arsenic poisoning event. In patients chronically poisoned by the consumption of well water with elevated levels of arsenate [As(V)], elevated 8-OHdG concentrations in urine were also observed. A significant correlation between the 8-OHdG levels and arsenic levels in the urine was observed in 82 patients with chronic poisoning. Thus, evidence of oxidative DNA damage occurred in acute arsenic poisoning by arsenite [As(III)] and in chronic arsenic poisoning by As(V). In chronic poisoning patients provided low-arsenic drinking water, evidence of DNA damage subsided between 9 months and 1 year after the high levels of arsenic intake were reduced. The initial level of arsenic exposure appeared to dictate the length of this recovery period. These data indicate that some aspects of chronic and acute arsenic poisoning may be reversible with the cessation of exposure. This knowledge may contribute to our understanding of the risk elevation from arsenic carcinogenesis and perhaps be used in a prospective fashion to assess individual risk.
Department of Preventive Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan. h2yama@marianna-u.ac.jp
Hiroshi
H
Yamauchi
Yoshito
Y
Aminaka
Katsumi
K
Yoshida
Guifan
G
Sun
Jingbo
J
Pi
Michael P
MP
Waalkes
D000080242:8-Hydroxy-2'-Deoxyguanosine / Q000031:analogs & derivatives; D000293:Adolescent; D000328:Adult; D000368:Aged; D020261:Arsenic Poisoning / Q000378:metabolism* / Q000401:mortality; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004249:DNA Damage / Q000187:drug effects*; D005260:Female; D006131:Growth Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006147:Guanine / Q000031:analogs & derivatives* / Q000652:urine*; D006801:Humans; D007223:Infant; D007564:Japan; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage / Q000009:adverse effects*
D001152:Arsenicals; D006131:Growth Inhibitors; D010087:Oxides; D006147:Guanine; C078307:8-oxo-7,8-dihydrodeoxyguanine; D000080242:8-Hydroxy-2'-Deoxyguanosine; D000077237:Arsenic Trioxide